CSIMarket
 


Revance Therapeutics Inc   (RVNC)
Other Ticker:  
 

Revance Therapeutics Inc 's Leverage Ratio

RVNC's quarterly Leverage Ratio and Total Liabilities, Equity growth


In IV Quarter 2023 Revance Therapeutics Inc had stockholder deficit.

Within Major Pharmaceutical Preparations industry Revance Therapeutics Inc achieved the lowest Leverage Ratio in the forth quarter 2023. While total ranking remained the same in the forth quarter 2023 compared to the previous quarter at no. .

Explain Leverage Ratio?
Who are RVNC Customers?
What are RVNC´s Total Liabilities?


RVNC Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change - - - - -81.6 %
Y / Y Total Liabilities Change 10.67 % 12.87 % 1.1 % -6.44 % 26.91 %
Leverage Ratio MRQ - - 21.31 - 45.18
RVNC's Total Ranking # # # # #
Seq. Equity Change - - - - -91.35 %
Seq. Total Liabilities Change -1.35 % 11.9 % -0.65 % 0.91 % 0.6 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Revance Therapeutics Inc 's Equity $ -152 Millions Visit RVNC's Balance sheet
Revance Therapeutics Inc 's Total Liabilities $ 630 Millions Visit RVNC's Balance sheet
Source of RVNC's Sales Visit RVNC's Sales by Geography


Cumulative Revance Therapeutics Inc 's Leverage Ratio

RVNC's Leverage Ratio for the trailling 12 Months

RVNC Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth - - - - -81.6 %
Y / Y Total Liabilities TTM Growth 10.67 % 12.87 % 1.1 % -6.44 % 26.91 %
Leverage Ratio TTM - - 14.39 17.63 12.77
Total Ranking TTM
Seq. Equity TTM Growth - - - - -91.35 %
Seq. Total Liabilities TTM Growth -1.35 % 11.9 % -0.65 % 0.91 % 0.6 %


On the trailing twelve months basis During the 12 months period ending IV Quarter 2023 company had stockholder deficit.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry RVNC recorded the lowest Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Leverage Ratio?
Who are RVNC Customers?
What are RVNC´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity

Date modified: 2024-02-29T16:57:27+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com